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Abstract
Background: Hepatitis C virus (HCV) infection is a major global public health problem in both
developed and developing countries. The prevalence and genetic diversity of HCV in pregnant
women in Gabon, central Africa, is not known. We therefore evaluated the prevalence and the
circulating genotypes of HCV in a large population cohort of pregnant women.
Methods: Blood samples (947) were collected from pregnant women in the five main cities of the
country. The prevalence was evaluated by two ELISA tests, and the circulating genotypes were
characterized by sequencing and phylogenetic analysis.
Results: Twenty pregnant women (2.1%) were infected with HCV. The seroprevalence differed
significantly by region (p = 0.004) and increased significantly with age (p = 0.05), being 1.3% at 14–
20 years, 1.1% at 21–25 years, 1.9% at 26–30 years, 4.1% at 31–35 years and 6.0% at > 35 years.
Sequencing in the 5'-UTR and NS5B regions showed that the circulating strains belonged to
genotypes 4 (4e and 4c).
Conclusion: We found that the HCV seroprevalence in pregnant women in Gabon is almost as
high as that in other African countries and increases with age. Furthermore, only genotype 4 (4e
and 4c) was found. More extensive studies aiming to evaluate the prevalence and heterogeneity of
HCV genotypes circulating in the general population of the country are needed.
Background
Hepatitis C virus (HCV) infection is a major global public
health problem in both developed and developing coun-
tries. More than 170 million people are chronically
infected with HCV worldwide, and the infection results in
the development of chronic liver diseases, including liver
cirrhosis and hepatocellular carcinoma. HCV has been
clustered into six distinct genotypes and numerous sub-
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types on the basis of nucleic acid sequence [1]. Genotyp-
ing of HCV strains is an important tool for
epidemiological and clinical purposes; in particular,
examination of sequence diversity can aid understanding
of different patterns of serological reactivity, virulence and
response to treatment [2,3].
Genotypes 1, 2 and 3 are distributed widely throughout
western countries, whereas types 5 and 6 are largely con-
fined to South Africa and southeast Asia, respectively, and
type 4 was first found predominantly in the Middle East
[4] and then in central Africa [5-7]. Data on HCV preva-
lence and molecular epidemiology are available for only a
few African countries. In Gabon, central Africa, the sero-
prevalence was previously reported to be up to 6.5% in
the general population of the eastern part of the country
[8], and genotype 4 was found by screening a few
sequences [7]. These data are based on small groups of
individuals and third-generation enzyme-linked immu-
nosorbent assays (ELISAs), molecular (reverse tran-
scriptase polymerase chain reaction (RT-PCR)) assays
having rarely been used. Furthermore, no data are availa-
ble on the presence of circulating HCV or the genotypes in
pregnant women in Gabon. A serological and molecular
study was therefore undertaken on a large population
cohort of pregnant women in the five main cities of the
country.
Methods
Area and study population
Gabon occupies 270 000 km2 in the Gulf of Guinea near
the equator, with tropical forest covering three-quarters of
the territory. The population was estimated in 2003 to be
1 273 000 persons, belonging to more than 40 ethnic
groups.
To determine the prevalence and the circulating genotypes
of HCV in pregnant women in Gabon, five sentinel sites
were selected: Libreville, the capital, in the north-west;
Port-Gentil, the port and economic capital in the west;
Lambaréné, in the centre of the country; Franceville in the
south-east; and Oyem in the north-east (Figure 1).
Between January and March 2005, blood samples were
collected from all pregnant women at their first antenatal
examination, after full informed consent had been
obtained. The samples were anonymous, but age and geo-
graphic origin were retained. The study obtained ethical
clearance from the public health authorities (Ministry of
Public Health and the "Programme National de Lutte con-
tre le Sida" in Gabon).
Serological tests
All samples were screened for anti-HCV antibodies with a
commercial third-generation ELISA (Monolisa, anti-HCV
Plus version 2, Bio-Rad, Marne-La-Coquette, France). The
results of the assay were expressed quantitatively as the
ratio of the optical density of the test sample to the calcu-
lated cut-off absorbance, as recommended by the manu-
facturer. Sera with ratios > 1.1 were considered to be
positive, sera with R values of 0.9–1.1 were recorded as
indeterminate, whereas those with R values < 0.9 were
considered negative. Positive and indeterminate sera were
re-tested with another third-generation ELISA assay,
Innotest HCV Ab IV (Innogenetics NV HCV, Gand, Bel-
gium). Samples were considered HCV positive when they
were positive in the two ELISA tests.
HCV amplification and molecular and phylogenetic 
analysis
Viral RNA was extracted from 140 μl of plasma with a
Qiamp® viral mini kit according to the manufacturer's pro-
tocol (Qiagen, Courtaboeuf, France). The extracted RNA
was used as a template and amplified by nested RT-PCR
with primers specific to the 5'UTR (5' non-coding region),
as described previously [9,10]. Reverse transcription and
first amplifications were performed with a Titan One Tube
RT-PCR kit (Roche Diagnostics, Mannheim, Germany),
according to the manufacturer's protocol. A portion of the
NS5B region was also amplified with degenerated prim-
ers, as described previously [11], and then sequenced
according to standard procedures. The HCV sequences
and phylogenetic results were studied as reported previ-
ously [11]. The GenBank accession numbers of the new
NS5b sequences are EU0334530 to EU0334534, and
those of the 5'UTR sequences are  to EU0334545.
Statistical analysis
Statistical analysis was performed by the chi-squared test
with Yates' correction, and the prevalences and odds ratios
were calculated. The corresponding 95% confidence inter-
vals were reported as measures of statistical significance.
Analyses were performed with Epi-Info (version 6.04dfr,
ENSP-Epiconcept-InUS, 2001).
Results
HCV prevalence in pregnant women
Between January and March 2005, sera from all 947 preg-
nant women recruited at the five sentinel sites were
screened for HCV antibodies with the two ELISA tests; 20
pregnant women (2.1%) were found to be seropositives
for HCV (Table 1). The seroprevalence differed signifi-
cantly by region (p = 0.004), with the highest prevalence
(4.9%) in Franceville (Haut Ogooué region in the south-
east) and no cases in Port Gentil. There was a significant
increase in HCV seroprevalence with age (p = 0.05), being
1.3% at 14–20 years, 1.1% at 21–25 years, 1.9% at 26–30
years, 4.1% at 31–35 years and 6.0% at > 35 years (Table
1).BMC Infectious Diseases 2008, 8:82 http://www.biomedcentral.com/1471-2334/8/82
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Map of Gabon in central Africa with the selected sentinel sites at which blood was collected from pregnant women Figure 1
Map of Gabon in central Africa with the selected sentinel sites at which blood was collected from pregnant 
women.
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HCV RNA detection and molecular analysis of circulating 
genotypes
HCV RNA targeting 5'-UTR was found in 13 of the 20 pos-
itive samples, showing that 1.3% of the pregnant women
were viraemic. Sequencing in the 5'-UTR region was suc-
cessful for 11 RNA-positive isolates (Table 2). BLAST
searches of the 5'-UTR sequences classified the 11 strains
as genotype 4. Of these, nine belonged to genotype 4e,
with 99–100% homology with the reference sequences
GAB809 (L29625) and CAM73 (L29591) from Gabon
and Cameroon, respectively [12]. The other two
sequences belonged to genotype 4c, with 98% homology
with the reference sequences Z6 (M84862) and GB358
(L29608) from Zaire and Gabon, respectively [13] (Table
2).
To confirm the circulating genotypes obtained with 5'-
UTR sequences and for phylogenetic analysis, the NS5B
Table 1: Prevalence of antibodies to hepatitis C virus (HCV) in pregnant women in Gabon (central Africa) by geographical area and 
age group
Variable HCV antibodies
No. positive/no. tested % Odds ratio 95% CI
Sentinel site
Port Gentil 0/168 0
Lambaréné 3/331 0.9 0.33 0.1–1.13
Libreville 5/199 2.5 1.29 0.46–3.59
Oyem 3/68 4.4 2.39 0.68–8.37
Franceville 9/181 4.9 3.64 1.49–8.92
Age range (years)
14–20 4/293 1.3 0.57 0.19–1.72
21–25 3/266 1.1 0.46 0.13–1.58
26–30 4/202 1.9 0.94 0.31–2.84
31–35 5/120 4.1 2.4 0.86–6.73
> 35 4/66 6.0 3.5 1.15–10.94
All 20/947 2.1
Table 2: Epidemiological status and results of molecular screening and 5'UTR sequence analysis for the 20 serologically HCV-positive 
pregnant women in Gabon, central Africa.
Sample Age (years) Region PCR 5'UTR BLAST % homology with accession number Subtype Accession number
Gab104 32 Lambaréné Positive 98 L29608 4c EU334535
Gab121 18 Lambaréné Negative - - -
Gab977 26 Lambaréné Positive 99 L29625 4e EU334536
Gab652 16 Libreville Positive 100 L29625 4e EU334537
Gab704 28 Libreville Positive 99 L29625 4e EU334538
Gab705 21 Libreville Negative - - -
Gab757 21 Libreville Negative - - -
Gab770 33 Libreville Positive 100 L29591 4e EU334539
Gab1089 23 Franceville Positive 100 L29625 4e EU334540
Gab1115 40 Franceville Negative - - -
Gab1139 26 Franceville Positive 99 L29625 4e EU334541
Gab1148 19 Franceville Positive 98 M84862 4c EU334542
Gab1174 29 Franceville Positive 100 L29591 4e EU334543
Gab1192 30 Franceville Negative - - -
Gab1213 34 Franceville Negative - - -
Gab1228 15 Franceville Positive 99 L29625 4e EU334544
Gab1229 31 Franceville Positive NA NA NA
Gab1664 25 Oyem Negative - - -
Gab1669 19 Oyem Positive NA NA NA
Gab1670 19 Oyem Positive 99 L29625 4e EU334545
NA, not available; only partial sequence of the amplicon could be obtained.BMC Infectious Diseases 2008, 8:82 http://www.biomedcentral.com/1471-2334/8/82
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regions of three strains were amplified and sequenced. We
also amplified and sequenced two new positive samples
obtained from routinely screened pregnant women in the
region with the highest HCV prevalence (Franceville).
These two samples were also included in the phylogenetic
analysis. Sequence analysis of the NS5B region confirmed
that the strains from pregnant women were closely related
to genotypes 4e and 4c, with 94.5% and 93.7% homology
with other strains from Gabon, as described previously
[12]. Phylogenetic analysis of the NS5B region confirmed
the sequence homology analysis, showing that the strains
from pregnant women in Gabon belonged to genotypes
4c and 4e (Figure 2). Within genotype 4e, our strains clus-
tered with strains from Cameroon and with other strains
from Gabon described previously [12]. In genotype 4c,
the strains from Gabon were closely related to other
strains identified previously by Stuyver et al. (1994).
Discussion
We found an overall seroprevalence of HCV in pregnant
women in Gabon of 2.1%, which is similar to that in
other African countries, such as Cameroon (1.9%) [14]
and Burkina Faso (2%) [15]. The prevalence in our study
was lower than that described previously in the general
population of eastern Gabon (6.5%) [8]. This difference
could be related to age, as we observed an increasing prev-
alence with age and low prevalences in the youngest age
groups (Table 1). Similar observations have been made in
previous studies in several African countries, including
Cameroon and the Democratic Republic of the Congo, in
both pregnant women and the general population
[14,16]. Although studies to evaluate the routes of HCV
transmission in Africa are needed [17], ritual procedures,
such as scarification and tattooing, which are common
tribal customs in various areas of Gabon, may facilitate
transmission [18]. Furthermore, in rural health centres in
Gabon, drugs such as antibiotics are commonly given by
intramuscular injection, and the sterilization procedures
are often inadequate, increasing the risk for HCV trans-
mission. People are therefore exposed to new infection
throughout their lives. This might explain in part the
increasing prevalence of HCV with age.
We also showed that HCV seroprevalence differed signifi-
cantly by region. Many factors can influence the transmis-
sion of HCV in Africa, including environmental, ethnic,
ritual (see above), economic and genetic factors. In Egypt,
it was reported that transmission of HCV was related to
extensive antischistosomiasis injection campaigns [19]. It
is not known whether previous vaccination campaigns in
Gabon had the same effects in various areas of the coun-
try. Further epidemiological, molecular and genetic stud-
ies are required to determine the factors responsible for
the high prevalence of HCV in some regions of Gabon.
Of the 20 seropositive women, seven were ELISA-positive
but RNA-negative. These seven samples also had a low
ratio in the two ELISA tests. It has been reported previ-
ously that during the natural history of HCV infection,
20–30% of infected individuals eliminate the virus spon-
taneously [20,21]. Results similar to ours were obtained
in studies conducted in Cameroon and Japan [14,22]. The
presence of HCV antibodies in the pregnant women in
our study might have been due to a previous infection.
We also showed that the HCV circulating in pregnant
women in Gabon belongs to genotype 4 (4e and 4c). In a
previous study, Xu et al. [7] published three sequences of
HCV selected from 1172 persons in the general popula-
tion of Gabon. Sequence comparisons showed that these
three sequences were closely related to genotype 4, and
the authors suggested that they might be related to geno-
type 4c or to 4d as described by Buck et al. [13]. In our
study, the sequences of 11 samples were also found to be
closely related to genotypes 4c and 4e. These two studies
thus confirm that genotype 4 is the only genotype circulat-
ing in Gabon.
In our study, we also found that 4e predominates in five
widely separated geographical regions of the country. Sub-
Saharan Africa is known to have a wide diversity of geno-
types 1, 2, and 4 and a remarkable diversity of subtypes
[6,11,23]; genotypes 4 and 5 predominate in several Afri-
can countries [24-26], and genotype 4f has been described
in Cameroon. We found only genotypes 4e and 4c in preg-
nant women in Gabon. Indeed, the plasma samples used
in the present study, obtained after screening for HIV,
HTLV, HBV/HDV and HEV, were insufficient to perform
more sequence analyses. However, the two strains
obtained from further routinely screened pregnant
women in the region of the highest HCV prevalence
(Franceville) confirm, however, that the circulating strains
in this population belong to genotype 4 (4c and 4e). A
larger study in the general population is needed to better
characterize the circulating genotypes.
Conclusion
Our study represents the first serological and molecular
epidemiological investigation on HCV in a homogeneous
population in Gabon. We showed that the HCV seroprev-
alence in pregnant women in Gabon is almost as high as
that in other African countries and increases with age.
Thus, preventive measures to decrease the spread and
transmission of HCV in Gabon are warranted. These
measures should include systematic HCV screening of
pregnant women, in order to counsel them about the risk
for HCV transmission and the development of associated
diseases.BMC Infectious Diseases 2008, 8:82 http://www.biomedcentral.com/1471-2334/8/82
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Phylogenetic analysis of HCV NS5B sequences Figure 2
Phylogenetic analysis of HCV NS5B sequences. A neighbour-joining phylogenetic tree was constructed from Gabonese 
isolates from pregnant women, and published reference sequences for the various HCV genotypes were obtained from Gen-
Bank. The Kimura two-parameter method of estimating genetic distance was used. Numbers next to the nodes of the tree rep-
resent bootstrap values (1000 replicates). In genotype 4, sequences found in Gabon are indicated in bold. The GenBank 
accession numbers of the new NS5b sequences of HCV from Gabon are EU0334530 to EU0334534.
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Only genotype 4 (4e and 4c) was found in these pregnant
women. More extensive studies aiming to evaluate the
heterogeneity of HCV genotypes in samples collected
from the general population of the country are needed.
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